De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation

BACKGROUND: Limited data are available on biological therapy de-escalation after prior escalation in inflammatory bowel disease (IBD) patients. This study aimed to assess the frequency and success rate of de-escalation of biological therapy in IBD patients after prior dose escalation and to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Pepijn W. A., Smits, Lisa J. T., Te Groen, Maarten, West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Römkens, Tessa E. H., Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2022
Materias:
Original Articles: Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983943/
https://www.ncbi.nlm.nih.gov/pubmed/34974465
http://dx.doi.org/10.1097/MEG.0000000000002336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983943/
https://www.ncbi.nlm.nih.gov/pubmed/34974465
http://dx.doi.org/10.1097/MEG.0000000000002336

Ejemplares similares